Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus

  • Sandeep K. Mallipattu
  • , Emily J. Gallagher
  • , Derek LeRoith
  • , Ruijie Liu
  • , Anita Mehrotra
  • , Sylvia J. Horne
  • , Peter Y. Chuang
  • , Vincent W. Yang
  • , John C. He

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

A large body of research has contributed to our understanding of the pathophysiology of diabetic nephropathy. Yet, many questions remain regarding the progression of a disease that accounts for nearly half the patients entering dialysis yearly. Several murine models of diabetic nephropathy secondary to Type 2 diabetes mellitus (T2DM) do exist, and some are more representative than others, but all have limitations. In this study, we aimed to identify a new mouse model of diabetic nephropathy secondary to T2DM in a previously described T2DM model, the MKR (MCK-KR-hIGF-IR) mouse. In this mouse model, T2DM develops as a result of functional inactivation of insulin-like growth factor-1 receptor (IGF-1R) in the skeletal muscle. These mice are lean, with marked insulin resistance, hyperinsulinemia, hyperglycemia, and dyslipidemia and thus are representative of nonobese human T2DM. We show that the MKR mice, when under stress (high-fat diet or unilateral nephrectomy), develop progressive diabetic nephropathy with marked albuminuria and meet the histopathological criteria as defined by the Animal Models of Diabetic Complications Consortium. Finally, these MKR mice are fertile and are on a common background strain, making it a novel model to study the progression of diabetic nephropathy.

Original languageEnglish
Pages (from-to)F1008-F1017
JournalAmerican Journal of Physiology - Renal Physiology
Volume306
Issue number9
DOIs
StatePublished - 1 May 2014

Keywords

  • Diabetic nephropathy
  • Insulin-like growth factor-I receptor
  • Leptin
  • Type 2 diabetes mellitus

Fingerprint

Dive into the research topics of 'Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this